ImmuneOnco Biopharmaceuticals (Shanghai) Inc. By efain on Wed, 07/27/2022 - 14:18 Read more about ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Pardes Biosciences, Inc. By efain on Fri, 06/24/2022 - 13:27 Read more about Pardes Biosciences, Inc.
Veralox Therapeutics Inc By efain on Wed, 06/08/2022 - 13:27 Read more about Veralox Therapeutics Inc
Shanghai SIMR Biotechnology Co., Ltd By efain on Wed, 06/08/2022 - 12:53 Read more about Shanghai SIMR Biotechnology Co., Ltd
Expanded Access Protocol for Patients With Eosinophilic Esophagitis Read more about Expanded Access Protocol for Patients With Eosinophilic Esophagitis
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009 Read more about Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
